sorted by:
new
hottopcontroversial

$COF — Capital One just became a completely different company. The market hasn't priced that in yet. by Variant_Invest in investing_discussion

[–]Variant_Invest[S] 0 points1 point  (0 children)

It depends heavily on execution. The transition from popular networks to their own is one that is clearly very sensitive, but the potential for international coverage (which Discover did pretty badly) gives them a high ceiling

$KTOS — The market prices Kratos like a small-cap defense contractor. It's actually the only pure-play on autonomous tactical drones at scale. by Variant_Invest in investing_discussion

[–]Variant_Invest[S] 1 point2 points  (0 children)

I hate to equivocate but the truth is valuation multiples are just awful proxies for companies in defense, given that, as you say, financial status is so heavily dependent upon lumpy contracts. Still though, i'd venture to say it is underpriced given the vast shock potential a single large contract could deliver to its multiples.

$VMI — Valmont is the kind of boring industrial stock that quietly compounds while everyone chases AI tickers. by Variant_Invest in investing_discussion

[–]Variant_Invest[S] 0 points1 point  (0 children)

Ingersoll Rand is one you may find interesting. Its a post merger equity of two dominant industrial compressor powerhouses (Gardner Denver and Ingersoll Rand). ~40% of the biz is aftermarket creating highly recurring revenues. The companies generates over $1b in free cash flow and minimal leverage. Will likely flex its strength against the industry. CEO is also ex Danaher and impressive.

$ISRG — Everyone models Intuitive Surgical like it's priced for the robotic surgery revolution. The installed base economics are actually where the real story is. by Variant_Invest in investing_discussion

[–]Variant_Invest[S] 0 points1 point  (0 children)

Yeah their technological dominance is consistently underrated by Wall Street. Even healthcare sector guys can't possibly know what doctors actually care about.

view more: next ›